Chronic Kidney Disease: Detection and Evaluation

被引:9
|
作者
Gaitonde, David Y. [1 ]
Cook, David L. [1 ]
Rivera, Ian M. [1 ]
机构
[1] Dwight D Eisenhower Army Med Ctr, 300 E Hosp Rd, Ft Gordon, GA 30905 USA
关键词
GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; CYSTATIN-C; MORTALITY; METAANALYSIS; ALBUMINURIA; PREDICTION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Chronic kidney disease affects 47 million people in the United States and is associated with significant health care costs, morbidity, and mortality. Because this disease can silently progress to advanced stages, early detection is critical for initiating timely interventions. Multiple guidelines recommend at least annual screening with serum creatinine, urine albumin/creatinine ratio, and urinalysis for patients with risk factors, particularly diabetes mellitus, hypertension, and a history of cardiovascular disease. The U.S. Preventive Services Task Force found insufficient evidence to assess the balance of benefits and harms of screening for chronic kidney disease in the general population, and the American College of Physicians recommends against screening asymptomatic adults without risk factors. Persistently elevated serum creatinine and albuminuria are diagnostic and prognostic hallmarks of chronic kidney disease. Lower levels of albuminuria are associated with adverse renal and cardiovascular outcomes. Serum cystatin C is a novel biomarker that is most useful when a false-positive decreased estimated glomerular filtration rate calculated from serum creatinine is suspected. New guidelines incorporate albuminuria into the classification framework for chronic kidney disease and elaborate on identification of the disease, the frequency of follow-up, and recommendations for nephrology referral. Nephrology consultation is indicated for patients with an estimated glomerular filtration rate less than 30 mL per minute per 1.73 m(2), persistent urine albumin/creatinine ratio greater than 300 mg per g or urine protein/creatinine ratio greater than 500 mg per g, or if there is evidence of a rapid loss of kidney function. A multidisciplinary approach between primary care physicians, nephrologists, and other subspecialists for implementing early interventions, providing education, and planning for advanced renal disease is key for effective management. Copyright (C) 2017 American Academy of Family Physicians.
引用
收藏
页码:776 / 783
页数:8
相关论文
共 50 条
  • [41] Detection of chronic kidney disease in "HEALTHY" elderly people
    Nava, David
    Martin del Campo, Fabiola
    Ordaz, Susan
    Gonzalez, Liliana
    Cortes-Sanabria, Laura
    Rojas-Campos, Enrique
    Martinez-Ramirez, Hector
    Cueto-Manzano, Alfonso
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 86 - 86
  • [42] Consensus document for the detection and management of chronic kidney disease
    Martinez-Castelao, Alberto
    Gorriz, Jose L.
    Bover, Jordi
    Segura-de la Morena, Julian
    Cebollada, Jesus
    Escalade, Javier
    Esmatjes, Enric
    Facila, Lorenzo
    Gamorra, Javier
    Gracia, Silvia
    Hernand-Moreno, Julio
    Llisterri-Caro, Jose L.
    Mazon, Pilar
    Montanes, Rosario
    Morales-Olivas, Francisco
    Munoz-Torres, Manuel
    de Pablos-Velasco, Pedro
    de Santiago, Ana
    Sanchez-Celaya, Marta
    Suarez, Carmen
    Tranche, Salvador
    NEFROLOGIA, 2014, 34 (02): : 243 - 262
  • [43] CHRONIC KIDNEY DISEASE IN THE EVALUATION OF COMORBIDITY IN PATIENTS WITH CHRONIC HEART FAILURE
    Efremova, E.
    Shutov, A.
    ATHEROSCLEROSIS, 2020, 315 : E263 - E264
  • [44] Evaluation of cytogenetic alterations in patients of chronic kidney disease
    Samarth, Ravindra
    Tiwari, Rajnarayan
    Modi, Gopesh
    Soni, Kishore
    Banjare, Mohan
    Hasan, Shariq
    Jain, Sanjay
    INDIAN JOURNAL OF NEPHROLOGY, 2023, 33 (04) : 259 - 263
  • [45] A new approach to the evaluation of hyperphosphatemia in chronic kidney disease
    Savica, V.
    Calo, L. A.
    Granata, A.
    Caldarera, R.
    Cavaleri, A.
    Santoro, D.
    Monardo, P.
    Savica, R.
    Muraca, U.
    Bellinghieri, G.
    CLINICAL NEPHROLOGY, 2007, 68 (04) : 216 - 221
  • [46] Mental status evaluation of patients with chronic kidney disease
    Ok, Elif
    JOURNAL OF PSYCHIATRIC NURSING, 2013, 4 (01): : 54 - 54
  • [47] Automated Podocyte Quantification for Evaluation of Chronic Kidney Disease
    Santo, Briana
    Rosenberg, Avi
    Sarder, Pinaki
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1593 - 1594
  • [48] Automated Podocyte Quantification for Evaluation of Chronic Kidney Disease
    Santo, Briana
    Rosenberg, Avi
    Sarder, Pinaki
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1593 - 1594
  • [49] Evaluation of changes in corneal endothelium in chronic kidney disease
    Kanawa, Surbhi
    Jain, Kalpna
    Sagar, Vinod
    Yadav, Dinesh K.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (05) : 1080 - 1083
  • [50] EVALUATION OF CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Oueslati, I.
    Lahiani, S.
    Bouzid, K.
    Khiari, K.
    Kaaroud, H.
    Elfaleh, E.
    Bartkiz, A.
    Ben Abdallah, N.
    Abdelmoula, J.
    ATHEROSCLEROSIS, 2016, 252 : E152 - E152